OnQ Prostate

Cortechs.ai

OnQ Prostate is post-processing software that supports improved detection of clinically significant prostate cancer (PCa). It utilizes artificial intelligence and a patented advanced diffusion MRI technique called Restriction Spectrum Imaging (RSI) to increase the conspicuity of restricted water, a hallmark characteristic of aggressive cancer.

Information source: Vendor
Last updated: Dec. 1, 2020

General Information

General
Product name	OnQ Prostate
Company	Cortechs.ai
Subspeciality	Abdomen
Modality	MR
Disease targeted	Prostate cancer
Key-features	Color fusion map, restricted signal map
Suggested use	Before: stratifying reading process (non, single, double read), flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps)

Technical Specifications

Data characteristics
Population	patients at risk of prostate cancer
Input	multi-shell MRI sequence, T2 weighted MRI sequence
Input format	DICOM
Output	Color fusion map, restricted signal map
Output format	DICOM
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis	On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes

Regulatory

Certification
CE	No or not yet,
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	12-2019
Distribution channels	Nuance PIN, Siemens
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of installations, Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers